StockTipsArenaBeta

BUY Divi's Laboratories Limited — Prakash Gaba

BUYDivi's Laboratories Limited

byPrakash GabaHorizon: NA (inferred Intraday)18 Sept 2026, 9:09 am ISTvia CNBC Awaaz.

Entry₹9,346.5Inferred
Target₹9,500
Total upside +1.64% (call closed)
Stop loss₹9,300-0.50% risk
At expiry₹9,37318 Sept 2026, 3:05 pm
Expired+0.28%
Follow Prakash Gaba for new calls(20% target hit, 283 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 18 Sept 2026
2 supporting1 neutral0 opposing
Supports the BUY call (2)

2 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·17 Sept · yesterday

Divi's Laboratories posts 65% PAT surge in Q1FY27 on strong revenue growth

NewsGoogle News·15 Sept · 2d ago

(opens in new tab)
Neutral / worth noting (1)

2 quiet pharma stocks are making very different cash bets. Add to watchlist?

NewsGoogle News·15 Sept · 3d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.